Skip to main content

Table 1 The relationship between the expression of FBXW7 and the clinicopathological characteristics of TNBC patients

From: Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition

FBXW7

number of cases

(n = 80)

Low

(n = 40)

High

(n = 40)

p

Age

0.822572

 > 50 years

37

18

19

 

 ≤ 50 years

43

22

21

 

Tumor size (cm)

0.498962

 > 2

43

24

21

 

 ≤ 2

37

16

19

 

TNM

0.807006

 I–II

44

27

27

 

 III–IV

26

13

13

 

Lymph node

0.073278

 Negative

42

25

17

 

 Positive

38

15

23

 

Survival status

0.00022

 Live

50

17

33

 

 Death

30

23

7

 
  1. All data are shown as numbers. Associations of FBXW7 expression levels with clinical characteristics were evaluated using Pearson’s χ2 test, Statistical significance was set at p < 0.05 for all analyses
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us